Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5413_Библиотеки_им_академика_М_И_Перельмана
.pdf

Girish Kumar Gupta, Vinod Kumar (Eds.)
Chemical Drug Design
De Gruyter Graduate

Also of interest
Microencapsulation.
Giamberini, Fernandez Prieto, Tylkowski (Eds), 2015
ISBN 978-3-11-033187-5, e-ISBN 978-3-11-033199-8
Functional Materials.
For Energy, Sustainable Development and Biomedical Sciences
Leclerc, Gauvin (Eds.), 2014
ISBN 978-3-11-030781-8, e-ISBN 978-3-11-030782-5
Membrane Systems.
For Bioartificial Organs and Regenerative Medicine
De Bartolo, Curcio, Drioli, 2016
ISBN 978-3-11-026798-3, e-ISBN 978-3-11-026801-0
New-Generation Bioinorganic Complexes.
Jastrzab, Tylkowski (Eds.), 2016
ISBN 978-3-11-034880-4, e-ISBN 978-3-11-034890-3
Nanodispersions.
Tadros, 2016
ISBN 978-3-11-029033-2, e-ISBN 978-3-11-029034-9
Drug Metabolism and Personalized Therapy.
Official journal of the European Society of Pharmacogenomics and
Personalised Therapy
Adrián LLerena (Editor-in-Chief)
ISSN 2363-8907, e-ISSN 2363-8915

Chemical Drug
Design
Edited by
Girish Kumar Gupta, Vinod Kumar

Editors
Dr. Girish Kumar Gupta
Department of Pharmaceutical Chemistry
M. M. College of Pharmacy
Maharishi Markandeshwar University
Mullana-133207, Ambala
Haryana, India
Dr. Vinod Kumar
Department of Chemistry
Maharishi Markandeshwar University
Mullana-133207, Ambala
Haryana, India
ISBN 978-3-11-037449-0
e-ISBN (PDF) 978-3-11-036882-6
e-ISBN (EPUB) 978-3-11-039269-2
Library of Congress Cataloging-in-Publication data
A CIP catalog record for this book has been applied for at the Library of Congress.
Bibliographic information published by the Deutsche Nationalbibliothek
The Deutsche Nationalbibliothek lists this publication in the Deutsche Nationalbibliografie;
detailedbibliographic data are available on the Internet at http://dnb.dnb.de.
© 2016 Walter de Gruyter GmbH, Berlin/Boston
Typesetting: PTP-Berlin, Protago-TEX-Production GmbH, Berlin
Printing and binding: CPI books GmbH, Leck
Cover image: everythingpossible/iStock/thinkstock
Printed on acid-free paper
Printed in Germany
www.degruyter.com

Preface
Today, drugs for practically every disease are available or in the process of developing
to alleviate all diseases known to man and chemical drug design play an important
role in finding new drugs or medicines based on the knowledge of a biological target.
The drug molecules, generally organic substances, activate or deactivate the function
of the biomolecules like proteins, lipids, carbohydrates, nucleic acids, etc. which in
turn lead to the corresponding therapeutic benefits to the living being. Other classes
of compounds including inorganic or organometallic compounds are also useful as
drugs. Therefore, chemical drug design involves the design of small chemical compounds that can interact and bind efficiently to the biological target. In recent past,
though an exhaustive study has been conducted in the field of drug design, there is
still a great need of developing new drugs for future library. The present book is an
attempt to present an invaluable and informative addition to field of drug design and
discovery. The book contains eleven chapters contributed by international scientists
and academicians focused on overview of basics in chemical drug design and the
recent developments made in present scenario. The chapter 1 provides an overview of
some basic techniques used in chemical drug design. The chapter 2 gives an update on
recent developments in the field of drug designing paving the way for novel drug discovery and describes how knowledge of the state-of-art techniques has led researchers to find out the best method for the development of new drugs. Chapter 3 enlightens the new concept of structure and ligand based drug designing. It also covers in
detail about the 2D QSAR and 3D QSAR approaches, descriptors as well as different
parameters used in QSAR studies. The chapter 4 describes the drug design applied
to natural products against neglected diseases. It introduces general concepts, and
discusses the neglected diseases, reporting on some of the enzymatic targets studied
when developing new drugs to treat these ills. The chapter 5 describes the developments made of newer hybrid drugs from natural products, especially for the treatment
of infections and cancer. The advantage of this concept over a combinatorial chemistry approach is the high diversity and the inherent biological activity of the hybrids.
The chapter 6 describes how does the drug metabolism play a major role in the drug
design and discovery process and determine the fate of the prospective drugs. In
chapter 7, the anticancer rationale of mistletoe lectins (the carbohydrate-binding proteins) is discussed. Its mechanism of discrimination between cell surface antigens of
normal and cancer cells is also emphasized. The chapter 8 highlights the structuralactivity relationship of different classes of typical and atypical antipsychotic drugs
and provides some considerations concerning new treatment research. The chapter
9 describes the applications of high performance chromatographic techniques in the
standardization of herbal drugs. The study focuses on the various chromatographic
techniques, chemometric tools and interpretation of results by HCA & PCA in various
guggulu samples. In chapter 10, the role of copper and its complexes with reference
to toxicity level, sources, progress in the development of drugs and various important

VI Preface
discussions about the mode of action is discussed. Finally, chapter11 highlights the
various thiazole-containing drugs which are currently on the market or in clinical
trials are discussed with a special note on their synthesis and mechanism of biological action.
The target audience of the book include students, researchers, chemists, pharmacists and professionals who are involved in different studies related to medicinal
chemistry and drug design. We would like to acknowledge all the authors for their
contribution and assembled the whole book. We hope that it will enhance the knowledge of scientists towards various approaches for drug design and would encourage
them to dedicate their future research in understanding of relevant mechanisms and
applications for the development of novel therapeutics. With this we signed off by
reminding you to send feedbacks with your critiques and communiqués.
Girish Kumar Gupta
Vinod Kumar

Table of Contents
PrefaceV
Sreekanth Thota
1 Overview of chemical drug design
1.1 Drug design
1.2 Rational drug design
1.3 Ligand-based drug design
1
2
5
1.4 Structure-based drug design
1.5 Pharmacophore-based approaches
1.6 Structure-based approaches
1.7 New lead generation
1.8 Structure evaluation
1.9 Future directions
8
9
9
Meenakshi Rajpoot, Rajasri Bhattacharyya, Girish Kumar Gupta, Anil K. Sharma
2 Drug designing in novel drug discovery: Trends,scope and relevance
2.1 Introduction
2.2 Drug designing
2.3 Applications of SBDD
2.4 Applications of LBDD
15
16
24
25
2.5 Role of cheminformatics in drug discovery
2.6 Conclusion
26
1
6
8
8
26
15
Sumitra Nain, Garima Mathur, Girish Kumar Gupta, Sarvesh Paliwal
3 Structure- and ligand-based approaches in drug designing
3.1 Drug discovery
3.2 Drug design
3.3 Drug designing techniques
3.4 Quantitative Structure-Activity Relationship (QSAR)
3.5 Physicochemical parameters
3.6 Biological parameters
3.7 Statistical terms in QSAR
31
33
33
35
35
44
48
31
Luciana Scotti, Francisco J. B. Mendonça Júnior, Marcelo S. daSilva, Marcus T. Scotti
4 Drug design applied to natural products against neglected diseases
4.1 Natural products
4.2 Medicinal chemistry
4.3 Docking
58
4.4 Neglected diseases
4.5 Final considerations
53
56
59
79
53

VIII Table of Contents
Manu Sharma
5 Natural product hybrid compounds as drug leads
5.1 Introduction
87
5.2 Naturally occurring hybrids/conjugates of natural products
5.3 Synthetic hybrids of whole natural products
5.4 Conclusion
102
87
88
91
Komarla Kumarachari Rajasekhar
6 Drug metabolism
6.1 Introduction
6.2 Phase I Metabolic reactions
6.3 Oxidative mechanisms
6.4 Reductive reactions
6.5 Hydrolytic reactions
6.6 Phase II conjugation reactions
6.7 Factors affecting drug metabolism
107
107
108
114
139
145
148
156
Seema Patel and Girish Kumar Gupta
7 Mistletoe lectin: A promising cancer therapeutic
7.1 Introduction
165
7.2 Anticancer potency of bacteria/plant lectins
165
167
7.3 Anticancer potency of mistletoe and the underlying mechanisms
7.4 Mistletoe lectins
7.5 Future directions
7.6 Concluding remarks
170
174
175
168
Tamara Angelo and André São Pedro
8 Antipsychotics
8.1 Introduction
8.2 History
183
8.3 Etiology of schizophrenia and related psychoses
8.4 Potential mechanism of action of antipsychotics
183
183
184
185
8.5 Structure-activity relationships and pharmacology of the drugs
8.6 Research into future treatments for schizophrenia and related
psychoses
194
Prerna Sarup
9 Chemometric analysis: A novel tool for herbal drug analysis and
designing
9.1 Introduction
9.2 Experimental
9.3 Data analysis and quality evaluation
199
199
201
202
186

Table of Contents IX
9.4 Results and discussion
9.5 Conclusion
212
204
Subash Chandra Sahoo, Ramesh Kataria and S.K. Mehta
10 Copper and its complexes: A pharmaceutical perspectives
10.1 Introduction
10.2 Source of dietetic copper
215
217
10.3 Recommended concentration of copper for human diet
10.4 Copper consumption and suggestions
10.5 Mechanism of copper transport in humans
10.6 Copper deficiency and symptoms
10.7 Copper metabolism and major diseases
218
218
219
220
10.8 Copper metabolism and hypothesized health problems
215
217
223
10.9 Copper complexes as an emerging tool in pharmaceutical sciences
10.10 Concluding remarks
236
Sunil Kumar, Madhuri T. Patil, Ramesh Kataria, DeepakB.Salunke
11 Thiazole: A privileged scaffold in drug discovery
11.1 Introduction
243
11.2 Synthetic routes for the construction of the thiazole ring
11.3 Thiazole as privileged scaffold in synthetic drugs
11.4 Ritonavir
11.5 Nitazoxanide
11.6 Sulfathiazole
11.7 Thiabendazole
11.8 Fatostatin
11.9 Dasatinib
11.10 Tiazofurin
11.11 CYC116
11.12 NCH-31
11.13 TAK-715
11.14 Meloxicam
11.15 Nizatidine
11.16 Famotidine
11.17 Conclusion
252
259
260
262
263
265
267
268
269
271
272
274
275
277
243
247
252
231
Index
283
Соседние файлы в папке Библиотека им академика М.И. Перельмана
